Navigation Links
Study Suggests Link Between Hormone Melatonin and Type 2 Diabetes
Date:4/2/2013

By Serena Gordon
HealthDay Reporter

TUESDAY, April 2 (HealthDay News) -- Decreased levels of the hormone melatonin may be linked to the development of type 2 diabetes, according to new research.

A study of U.S. women found that those with the lowest levels of melatonin had more than twice the risk of type 2 diabetes compared to women with the highest levels of the hormone. This association held true even after the researchers controlled for other risk factors for type 2 diabetes, such as body weight and dietary habits.

But whether too little melatonin actually causes type 2 diabetes isn't clear. "We found an association between melatonin and type 2 diabetes; what we haven't got from this study is causality," said study lead author Dr. Ciaran McMullan, a research fellow at Brigham and Women's Hospital in Boston. "That's the next step of research."

The findings shouldn't change clinical management. "There's no evidence that taking melatonin will improve someone's chances of avoiding diabetes," McMullan said.

Results of the study, which was funded by the National Institutes of Health, appear in the April 3 issue of the Journal of the American Medical Association.

Melatonin is a hormone most commonly linked to sleep and the body's biological clock. The production of melatonin peaks about three to five hours after you fall asleep in the dark, and almost no melatonin is produced during the day, according to background information in the study. Sleep disruptions can affect melatonin production, as can exposure to more or less daylight, McMullan said.

People with type 2 diabetes, by far the more common form of diabetes, don't make enough insulin or use it properly. Insulin is a hormone needed to convert sugar (glucose) from foods into energy.

Melatonin receptors are found throughout the body, including in the islet cells of the pancreas, which produce insulin. This connection suggests melatonin may also play a role in glucose metabolism, according to the study.

McMullan and his colleagues reviewed data from the U.S. Nurses' Health Study. The researchers found 370 women who developed type 2 diabetes during the study period, from 2000 to 2012. They also selected 370 women without diabetes for comparison. Melatonin levels were obtained through urine samples.

When researchers compared women with the lowest levels of melatonin to those with the highest, they found that low levels increased the risk of developing type 2 diabetes by 2.17 times.

McMullan said it's not yet clear how melatonin might affect the risk of type 2 diabetes. "The next step is to look at whether we can adjust melatonin secretion in people, and to confirm whether or not melatonin is a modifiable risk factor for type 2 diabetes," he said.

Dr. Joel Zonszein, director of the clinical diabetes center at Montefiore Medical Center in New York City, said the study illustrates the complexity of type 2 diabetes. "But it doesn't prove that taking melatonin would cause a person to be more insulin sensitive," he said.

"While there is a correlation between melatonin and insulin resistance, we cannot tell from this study if low melatonin is the cause," Zonszein said. "We are far away from melatonin as a treatment."

In the United States, about 8 percent of residents have diabetes, but many don't know it. The disease, a leading cause of heart disease and stroke, is typically associated with obesity, sedentary lifestyle and older age.

More information

Learn more about preventing type 2 diabetes from the American Diabetes Association.

SOURCES: Ciaran McMullan, M.D., research fellow, Brigham and Women's Hospital, Boston; Joel Zonszein, M.D., director, clinical diabetes center, Montefiore Medical Center, New York City; April 3, 2013, Journal of the American Medical Association


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Suggests Link Between Hormone Melatonin and Type 2 Diabetes
(Date:6/28/2017)... FRANCISCO AND TEL AVIV (PRWEB) , ... June ... ... 3D-imaging sensor company whose technology makes it possible to see through objects, has ... challenging makers to create consumer apps with its fully programmable, Raspberry Pi-enabled 3D ...
(Date:6/28/2017)... ... June 28, 2017 , ... Drs. Steven Crandall, Karen ... treatment in Pittsburgh, PA, and Upper St. Clair, PA, without a referral. The doctors ... restoring the health of the temporomandibular joint and facial muscles that support it. ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... David B. Sosin, a founding ... Illinois, took over the post of 2nd Vice President for the Illinois State Bar ... installed as the ISBA’s 3rd Vice President in 2016 following a state-wide election and served ...
(Date:6/28/2017)... ... 2017 , ... Schneider Insurance and Financial, a Yellowstone County ... Montana, is announcing a focused charity effort to gather regional support for the ... Zoo Montana provide students with current knowledge on the characteristics and behaviors of ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly ... to survey data released today by the American Society for Dermatologic Surgery ... indicates the percentage of consumers considering a cosmetic medical procedure has doubled since ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)...  NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology company ... demonstrating positive biochemical outcomes related to more frequent hemodialysis ... will be presented at the ERA-EDTA Congress being held ... . The research was conducted by ... Europe (KIHDNEy) Cohort team ...
(Date:5/30/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... that it will be presenting at the 7th annual LD Micro ... Erez Raphael , CEO, of DarioHealth will be giving the presentation ... on June 6th & 7th, 2017 at the Luxe Sunset Bel ... micro-cap space. About LD Micro ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: